Heading Title
-
RegulatorySanofi Inc.U.S FDA
Nexviazyme® improves respiration and mobility long-term in Pompe disease patients
by adminby adminSummary : Two-year data shows Pompe disease patients treated with Nexviazyme® (avalglucosidase alfa) have sustained improvements in respiratory function and mobility. Sanofi has announced that patients living with late-onset Pompe disease …
-
Summary : Alterity Therapeutics have been granted a patent for compounds able to redistribute excess iron in the brain being developed as a treatment for neurodegenerative diseases including Alzheimer’s and …
-
Boehringer Ingelheim
Boehringer Ingelheim and OSE Immunotherapeutics To Present Biomarker Analyses from the Phase 1 Clinical Trial with First-in-Class SIRPα Inhibitor BI 765063 in Advanced Solid Tumors
by adminby adminSummary : OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE), today announced that early biomarker analyses from the ongoing Phase 1 clinical trial with SIRPα inhibitor BI 765063 in patients with advanced solid …
-
CompaniesPfizer
Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints
by adminby adminSummary : Pre-specified secondary endpoint showed 0-11 vaccine to placebo case split for medically attended C. difficile infection (CDI), corresponding to 100% vaccine efficacy Median CDI duration was 1 versus …
-
CompaniesIntellectual Property (IP)Patent LitigationPatentsPfizerWest-Coast Pharmaceutical works Ltd
Pfizer Inc filed a Patent Infringement suit against West-Coast Pharmaceutical works Ltd.
by adminby adminSummary : Pfizer Inc. (plaintiff) filed a patent infringement suit against West-Coast Pharmaceutical works Ltd. (defendant) for inviting manufacturers to contract with Pfizer concerning the manufacturing and marketing of 𝗣𝗮𝗹𝗯𝗼𝗰𝗶𝗰𝗹𝗶𝗯 …
-
Pharma Science & ResearchRoche
Roche’s Vabysmo to offer ‘fierce competition’ to Regeneron’s Eylea
by adminby adminSummary : Roche’s Vabysmo is having a strong start with doctors, but it has a long way to go if it wants to cut into Regeneron and Bayer’s $8.3B blockbuster …
-
GileadPharma Science & Research
Gilead drops unclear win for key Trodelvy breast cancer trial
by adminby adminSummary : Gilead Sciences has a lot of its oncology ambitions riding on Trodelvy’s success beyond its existing approvals. While investors have been waiting with bated breath for results from …
-
Agrochemicals
International Women’s Day 2022: History, Significance And This Year’s Theme
by adminby adminWomen’s Day 2022: The theme of 2022 International Women’s Day is “gender equality today for a sustainable tomorrow”. International Women’s Day is celebrated every year on March 8 to recognise …
-
CompaniesGlobal MarketPfizer
Pfizer Canada recalls BP drug on potential cancer-causing impurity
by adminby adminSummary : Pfizer Canada, a unit of Pfizer Recalling all lots of high blood pressure drug Inderal-LA (propranolol hydrochloride) extended release capsules, in 60 mg, 80 mg, 120 mg and 160 …
-
Summary : Six pharmaceutical majors Aurobindo, Biocon, Dr Reddy’s, JB Chemicals, Torrent Pharma and Zydus Healthcare have been shortlisted for the acquisition of Curatio Healthcare, the Chennai-based company focused on …
-
Global MarketPharma Science & Research
National science academies of the G7 states publish joint statement on the war in Ukraine
by adminby adminThe national science academies of the G7 states publish a joint statement on Russia’s attack on Ukraine. The science academies have been accompanying the annual meetings of the G7 states …
-
Summary : A new study has found that artificial intelligence (AI) apps helped protect small and medium-sized businesses against many of the risks that emerged during the COVID-19 pandemic – …
-
Boehringer IngelheimGlobal Market
Boehringer Ingelheim and Lifebit announce partnership to capture transformational value of health data
by adminby adminSummary : The leading research-driven biopharmaceutical company Boehringer Ingelheim and precision medicine software company Lifebit Biotech, Ltd. (Lifebit) today announce partnership in which Lifebit will support Boehringer Ingelheim in building …
-
Pharma Science & Research
Blood pressure medication shows benefits treating Type 1 diabetes
by adminby adminSummary : Use of the drug verapamil to treat Type 1 diabetes continues to show benefits lasting at least two years, researchers report in the journal Nature Communications. Patients taking …
-
CompaniesCovid DrugsModernaPfizerRegulatoryU.S FDA
Moderna and Pfizer are Well-Positioned to Take mRNA into the Future
by adminby adminSummary : It’s an understatement to note that the bottom lines for Moderna and Pfizer have been fattened by the success of the COVID-19 vaccines using mRNA technology the two …
-
Covid DrugsRegulatoryU.S FDA
Ocugen Ends Week on Low as FDA Rejects Covaxin EUA for Kids
by adminby adminSummary : The U.S. Food and Drug Administration turned down Ocugen’s Emergency Use Authorization (EUA) request for Covaxin in children 2 to 18 years. Covaxin is a COVID-19 vaccine the …
-
Agro Science & Research
Germany Sets Up a New Greenhouse Facility for Organic Vegetables
by adminby adminSummary : InVDH FolieKassen from the Netherlands has build a greenhouse in Germany. The greenhouse was built at Ackerlei Bioland Betrieb in Bruchkobel. In recent days, VDH FolieKassen from the Netherlands has …
-
Synopsis : Kocide 3000 is the technology from Kocide LLC which is a group company of Mitsui & Co., Ltd. It is being imported from USA. It has enhanced efficacy …
-
Summary : On Wednesday, Chief Minister Y S Jagan Mohan Reddy launched NABARD’s focus paper for Andhra Pradesh at its annual credit seminar in Tadepalli. The chief minister told NABARD …
-
India
PM Kisan: Rs 1.82 Lakh Crore Transferred Directly into Bank Accounts of 11 crore Farmers
by adminby adminSummary : Agriculture Minister Narendra Singh Tomar said that the government will lay emphasis on setting up more Farmer Producer Organizations (FPOs) in the country as part of its efforts …
-
Amgen Inc.CompaniesPharma Science & Research
Amgen, NHS strike deal to expand Lumykras access in UK as watchdog weighs its merits
by adminby adminSummary : While England’s drug-price watchdog continues to assess the value of Amgen’s lung cancer drug Lumykras, the company and the National Health Service have Struck a deal to make …
-
AstraZenecaPharma Science & Research
First RSV vaccine trial for infants offers significant results
by adminby adminSummary : Results from a phase 3 trial evaluating AstraZeneca and Sanofi’s jointly developed treatment nirsevimab – the first investigational long-acting antibody, designed to protect all infants from respiratory syncytial virus (RSV), with …
-
Global Market
World Wildlife Day 2022: Five Critically Endangered Species Threatened by Human Activity
by adminby adminWorld Wildlife Day is celebrated on March 3 each year since 2014 to raise awareness about endangered flora and fauna. Delicate ecological zones across the planet are getting damaged because …
-
WORLD WILDLIFE DAY 2022: Animals and plants have a huge contribution to our ecological system. They also contribute to the generic, social, economic, scientific, educational and human well-being of sustainable development. …
-
Lupin PharmaRegulatoryU.S FDA
Lupin launches Sevelamer Hydrochloride tablets in the United States used in treatment of kidney disease
by adminby adminHighligts : Sevelamer Hydrochloride Tablets, 800 mg is a generic equivalent of Renagel Tablets, 800 mg of Genzyme Corporation used in the treatment of kidney disease. Global pharma major Lupin …
-
Global MarketMerger / Acquisition
SeQuent Scientific acquires Brazil-based animal drug firm for $5 million
by adminby adminSummary : PE firm Carlyle-backed SeQuent Scientific has acquired 100% stake in Brazil-based Nourrie Sade e Nutrio Animal Ltd for $5mn (Rs36.2cr), via its wholly-owned subsidiary Alivira Animal Health. The …
-
Synopsis : Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, announced the appointment of Serina Fischer as its General Manager for India operations. The appointment is effective as of …
-
Merger / Acquisition
bdr: BDR looking to buy majority stake in drug plant in Belarus
by adminby adminSummary : BDR Pharma, the Mumbai-based drugmaker that raised around ₹750 crore earlier this year from Renuka Ramnath-led private equity (PE) fund Multiples Alternate Asset Management, is gearing up for …
-
Summary : Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced an initial donation of essential medicines to Ukraine. Roche vehemently condemns the violent invasion of the country. Roche is working …
-
RegulatoryU.S FDA
J&J, Legend Introduce New CAR-T Therapy to Multiple Myeloma Market
by adminby adminSummary : Johnson & Johnson’s partner, Legend Biotech, has been awarded U.S. Food and Drug Administration approval for its chimeric antigen receptor T-cell (CAR-T) therapy, Carvykti, for the treatment of …
-
GileadRegulatoryU.S FDA
FDA Rejects Gilead’s Long-Acting HIV Drug Over Vial Issues
by adminby adminSummary : The U.S. Food and Drug Administration issued a Complete Response Letter (CRL) to Gilead Sciences rejecting its New Drug Application (NDA) for lenacapavir. The NDA was under review …
-
AbbVieCompaniesMerger / Acquisition
AbbVie Bolsters Neuro Platform with $1B Syndesi Buy
by adminby adminSummary : AbbVie has bolstered its neuropsychiatric and neurodegenerative portfolio with the acquisition of Belgium-based Syndesi Therapeutics in a deal valued at up to $1 billion. With an upfront payment …
-
Global Market
Winners Announced in 16th Annual Stevie® Awards for Sales & Customer Servicef
by adminby adminWinners Announced in 16th Annual Stevie® Awards for Sales & Customer Service New Categories for 2022 Recognize Thought Leadership FAIRFAX, Va., March 01, 2022 (GLOBE NEWSWIRE) — Winners in the …
-
Global MarketPharma Science & Research
SAB Biotherapeutics Announces Publication of Nonclinical Data Demonstrating SAB-185 Has High Potency for Effectively Neutralizing Circulating and Emerging SARS-CoV-2 Variants
by adminby adminSummary : – In the FDA-conducted study, SAB-185 consistently demonstrated high avidity and high potency for effectively neutralizing a broad range of SARS-CoV-2 strains and variants through Delta -SAB-185 additionally …
-
Global Market
Bruker Releases CCS-Enabled TIMScore™ and TIMS DIA-NN 4D Proteomics Software
by adminby adminSummary : Bruker PaSER™ 2022 software now features TIMS DIA-NN processing for dia-PASEF® Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with TIMS DIA-NN identifies ~9000 protein groups from 200 …
-
Pharma Science & Research
MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
by adminby adminSynopsis : MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the grant of inducement stock options for an aggregate of …
-
Pharma Science & Research
Booster critical as COVID-19 vaccine-induced antibodies wane in 6 months, don’t protect against omicron
by adminby adminSummary : A new study using serum from human blood samples suggests neutralizing antibody levels produced by two-dose mRNA vaccines against the original and early variants of the SARS-CoV-2 virus …
-
Summary : As the COVID-19 pandemic continues to claim lives around the world, dairy scientists may have a surprising role to play. In a new report published in the Journal …
-
Pharma Science & Research
Healthy gut microbiome improves success of cancer treatment
by adminby adminSummary : The largest study to date has confirmed the link between the gut microbiome and the response to cancer immunotherapy therapy for melanoma. The study is published today in …
-
RegulatoryU.S FDA
Aquestive Therapeutics Presented Positive Topline Phase 1 Results for AQST-109 Epinephrine Oral Film at American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
by adminby adminSummary : Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives, presented …
-
March 1 represents Self-Injury Awareness Day (SIAD), an international awareness day that is dedicated to learning about behaviors like “cutting” and other intentional methods of self-injury —raising awareness and providing …
-
Zero Discrimination Day is an observance marked annually on March 1 by United Nations among other international organisations to promote equality and fairness before the law . The day was …
-
RegulatoryU.S FDA
Expert: Newly Appointed FDA Commissioner Robert Califf Is Perfectly Positioned to Advance the FDA’s Accelerated Approval Pathway
by adminby adminSummary : Peter Pitts, a former FDA associate commissioner and president of the Center for Medicine in the Public Interest, discusses the implications of Robert Califf’s appointment to lead the …
-
EuropePharma Science & Research
NICE recommends cenobamate for treatment of adult epilepsy patients in UK
by adminby adminSummary : NICE has issued a positive recommendation for Arvelle Therapeutics’ cenobamate (Ontozry), for the treatment of focal-onset seizures in adults with uncontrolled epilepsy in England and Wales. The Final …
-
Summary : Vaccine pioneers expand presence throughout Europe with a view to leveraging technology The biotechnology company, Moderna, has announced plans to expand its commercial network across six additional countries …
-
Global MarketPharma Science & Research
Scancell gains new facilities at The Oxford Science Park
by adminby adminSummary : British biotech company Scancell has expanded its research and development capabilities at one of the UK’s leading parks for science and technology companies – the Oxford Science Park …
-
Summary : Several FDA-approved drugs – including for type 2 diabetes, hepatitis C and HIV – significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human …
-
Sanofi Inc.
Late-breaking phase 3 data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly reduced itch and hives in patients with chronic spontaneous urticaria
by adminby adminSummary : Late-breaking phase 3 data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly reduced itch and hives in patients with chronic spontaneous urticaria In this Phase 3 trial, Dupixent added to standard-of-care antihistamines nearly doubled reduction in …
-
Global Market
ADDING MULTIMEDIA Capri EGM Acquires R&D Build-to-Suit for National Resilience, a Biomanufacturing Company Contracted by the DOD, Harvard, and Moderna
by adminby adminSummary : Capri EGM, an investment company specializing in corporate build-to-suit and sale leaseback financing and the acquisition of income-generating life science, R&D, and logistics real estate, has funded and …
-
RegulatoryU.S FDA
GC Pharma Receives Complete Response Letter From the U.S. FDA For ‘ALYGLO’
by adminby adminSummary : GC Pharma (KRX:006280) today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) in response to its Biologics License …